Genetic Analysis of Thyrotoxic Periodic Paralysis
NCT00443833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2007-03-06
Summary
Thyrotoxic periodic paralysis (TPP) is characterized by episodes of reversible hypokalemia and weakness in thyrotoxic patients. It is commonly found in males of Asian descent and is also seen in individuals having Native American or Hispanic ancestry. Therefore genetic etiology has been hypothesized. This study, we aim to find the susceptibility genes that associate with TPP. Both candidate genes approach and genome wide association study have been conducted.
Conditions
- Thyrotoxic Periodic Paralysis
Sponsors & Collaborators
-
Ramathibodi Hospital
lead OTHER
Principal Investigators
-
Wallaya Jongjaroenprasert, MD · Endocrinology Unit, Ramathibodi Hospital, Mahidol University
Eligibility
- Min Age
- 15 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-31
- Completion
- 2005-12-31
More Related Trials
-
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis.
NCT01916018 ·Status: COMPLETED ·Phase: NA
-
Genetic Study of Antithyroid Drugs Associated Agranulocytosis
NCT01977963 ·Status: UNKNOWN
-
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
NCT00316823 ·Status: COMPLETED ·Phase: NA
-
ThyrOp: A Study of Individual Subclinical Hypothyroidism After Hemithyroidectomy for Benign Nontoxic Goiter
NCT01358136 ·Status: UNKNOWN
-
Therapeutic Plasma Exchange in Thyrotoxicosis
NCT04485975 ·Status: COMPLETED
-
Clinical Validation of ThyroidPrint: A Gene Expression Signature for Diagnosis of Indeterminate Thyroid Nodules
NCT03309631 ·Status: UNKNOWN
-
L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia
NCT01306227 ·Status: COMPLETED ·Phase: PHASE3
-
Levothyroxine for Children With Euthyroid Sick Syndrome
NCT01631305 ·Status: COMPLETED ·Phase: PHASE4
-
Thiamine Supplement in Patients With Severe Hyperthyroidism
NCT02767245 ·Status: COMPLETED ·Phase: NA
-
Thalidomide in Treating Patients With Thyroid Cancer
NCT00026533 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic Susceptibility to Radiation Induced Thyroid Cancer
NCT04139096 ·Status: COMPLETED
-
Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
NCT00488644 ·Status: TERMINATED ·Phase: NA
-
Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation
NCT04392258 ·Status: UNKNOWN
-
Euthyroid Sick Syndrome (ESS) Effect on Traumatic Brain Injury Patients and Its Relation With GFAP Level
NCT04806672 ·Status: UNKNOWN
-
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
NCT00360074 ·Status: COMPLETED ·Phase: PHASE4
-
IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism
NCT04484116 ·Status: COMPLETED
-
rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter
NCT00275171 ·Status: COMPLETED ·Phase: PHASE2
-
ASQ Scores of Transient Hypothyroxinemia of Prematurity
NCT05901623 ·Status: COMPLETED
-
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Theophylline in Pseudohypoparathyroidism
NCT03718403 ·Status: RECRUITING ·Phase: PHASE4
-
Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale
NCT06286631 ·Status: RECRUITING
-
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
NCT00812149 ·Status: COMPLETED
-
Levothyroxine Treatment in Thyroid Benign Nodular Goiter
NCT00552253 ·Status: COMPLETED ·Phase: NA
-
More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated
NCT06439745 ·Status: COMPLETED
-
Recurrent Pregnancy Loss and Thyroid Disease
NCT03106935 ·Status: UNKNOWN ·Phase: EARLY_PHASE1